Neurophet Inc. (380550)
KRX SM KRX SM Primary Summary
380550 Chart
Neurophet Inc. (380550) FAQ
What is the stock price today?
On which exchange is it traded?
What is its stock symbol?
Does it pay dividends? What is the current yield?
What is its market cap?
Has Neurophet Inc. ever had a stock split?
Neurophet Inc. Profile
| - Industry | - Sector | Mr. Junkil Been CEO | KRX SM Exchange | KR7380550004 ISIN |
| South Korea Country | - Employees | - Last Dividend | - Last Split | - IPO Date |
Overview
Neurophet Inc. is a pioneering healthcare technology firm dedicated to the development of artificial intelligence-driven solutions aimed at addressing neurological disorders. Founded in 2016 and based in Seoul, South Korea, the company is at the forefront of integrating advanced neuroscience with AI to improve the diagnosis and treatment of brain-related ailments. Neurophet's innovative approach is designed to enhance clinical outcomes by providing healthcare professionals with tools that improve diagnostic accuracy and treatment strategies, particularly for complex conditions like Alzheimer’s disease and multiple sclerosis. The recent obtaining of FDA 510(k) clearance for their AI software highlights Neurophet's significant position in the evolving landscape of medical AI and neurotechnology, marking it as a leader committed to enhancing global healthcare practices.
Products and Services
- Neurophet AQUA: This AI-powered software facilitates the diagnosis of neurological diseases through advanced brain imaging analysis, particularly utilizing MRI scans. It aids clinicians in interpreting complex imaging data to make more accurate and timely diagnoses.
- Neurophet SCALE PET: This innovative tool quantifies biomarkers in PET imaging, providing crucial information about neurological conditions. By measuring these biomarkers, healthcare providers can better understand disease progression and tailor treatment plans accordingly.
- Simulation tools for brain electrical stimulation: Neurophet offers simulation technology designed for brain electrical stimulation, which assists in developing and evaluating treatment plans for patients suffering from various neurological conditions. These tools enhance the effectiveness of electrical stimulation interventions.
- Non-invasive rehabilitation device: Designed to support rehabilitation efforts for patients with brain disorders, this innovative device utilizes non-invasive methods to promote recovery and improve quality of life for individuals affected by neurological issues.
Neurophet's comprehensive suite of products empowers clinicians and researchers to enhance diagnostic precision, refine treatment pathways, and ultimately improve patient outcomes in the realm of neurological healthcare.
